17-50192466-C-G

Variant summary

Our verdict is Benign. The variant received -16 ACMG points: 0P and 16B. BP4_StrongBP6_Very_StrongBS2

The NM_000088.4(COL1A1):​c.1983+9G>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000613 in 1,605,990 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.00053 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00062 ( 2 hom. )

Consequence

COL1A1
NM_000088.4 intron

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:11

Conservation

PhyloP100: -1.02

Publications

0 publications found
Variant links:
Genes affected
COL1A1 (HGNC:2197): (collagen type I alpha 1 chain) This gene encodes the pro-alpha1 chains of type I collagen whose triple helix comprises two alpha1 chains and one alpha2 chain. Type I is a fibril-forming collagen found in most connective tissues and is abundant in bone, cornea, dermis and tendon. Mutations in this gene are associated with osteogenesis imperfecta types I-IV, Ehlers-Danlos syndrome type VIIA, Ehlers-Danlos syndrome Classical type, Caffey Disease and idiopathic osteoporosis. Reciprocal translocations between chromosomes 17 and 22, where this gene and the gene for platelet-derived growth factor beta are located, are associated with a particular type of skin tumor called dermatofibrosarcoma protuberans, resulting from unregulated expression of the growth factor. Two transcripts, resulting from the use of alternate polyadenylation signals, have been identified for this gene. [provided by R. Dalgleish, Feb 2008]
COL1A1 Gene-Disease associations (from GenCC):
  • Caffey disease
    Inheritance: AD Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: G2P, Labcorp Genetics (formerly Invitae), ClinGen, Orphanet, Ambry Genetics
  • COL1A1-related Ehlers-Danlos syndrome
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • combined osteogenesis imperfecta and Ehlers-Danlos syndrome 1
    Inheritance: AD Classification: DEFINITIVE, MODERATE Submitted by: ClinGen, Ambry Genetics
  • Ehlers-Danlos syndrome
    Inheritance: AD Classification: DEFINITIVE Submitted by: G2P
  • Ehlers-Danlos syndrome, arthrochalasia type
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: ClinGen, G2P, Labcorp Genetics (formerly Invitae), Genomics England PanelApp, Orphanet
  • osteogenesis imperfecta
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • osteogenesis imperfecta type 1
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Orphanet
  • osteogenesis imperfecta type 2
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Orphanet
  • osteogenesis imperfecta type 3
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: ClinGen, Labcorp Genetics (formerly Invitae), Orphanet
  • osteogenesis imperfecta type 4
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, G2P, Orphanet
  • Ehlers-Danlos syndrome, classic type, 1
    Inheritance: AD Classification: MODERATE Submitted by: ClinGen
  • Ehlers-Danlos syndrome, classic type
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • Ehlers-Danlos/osteogenesis imperfecta syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • high bone mass osteogenesis imperfecta
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -16 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.81).
BP6
Variant 17-50192466-C-G is Benign according to our data. Variant chr17-50192466-C-G is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 447140.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS2
High AC in GnomAd4 at 80 AD gene.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000088.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
COL1A1
NM_000088.4
MANE Select
c.1983+9G>C
intron
N/ANP_000079.2P02452

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
COL1A1
ENST00000225964.10
TSL:1 MANE Select
c.1983+9G>C
intron
N/AENSP00000225964.6P02452
COL1A1
ENST00000861334.1
c.1983+9G>C
intron
N/AENSP00000531393.1
COL1A1
ENST00000861339.1
c.1983+9G>C
intron
N/AENSP00000531398.1

Frequencies

GnomAD3 genomes
AF:
0.000526
AC:
80
AN:
152198
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000121
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000523
Gnomad ASJ
AF:
0.00576
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00113
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000441
Gnomad OTH
AF:
0.00239
GnomAD2 exomes
AF:
0.000551
AC:
130
AN:
235884
AF XY:
0.000574
show subpopulations
Gnomad AFR exome
AF:
0.000132
Gnomad AMR exome
AF:
0.000365
Gnomad ASJ exome
AF:
0.00359
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00110
Gnomad NFE exome
AF:
0.000486
Gnomad OTH exome
AF:
0.00120
GnomAD4 exome
AF:
0.000623
AC:
905
AN:
1453792
Hom.:
2
Cov.:
33
AF XY:
0.000623
AC XY:
450
AN XY:
722388
show subpopulations
African (AFR)
AF:
0.0000904
AC:
3
AN:
33194
American (AMR)
AF:
0.000463
AC:
20
AN:
43216
Ashkenazi Jewish (ASJ)
AF:
0.00385
AC:
100
AN:
25974
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39216
South Asian (SAS)
AF:
0.00
AC:
0
AN:
85324
European-Finnish (FIN)
AF:
0.00122
AC:
65
AN:
53088
Middle Eastern (MID)
AF:
0.000348
AC:
2
AN:
5740
European-Non Finnish (NFE)
AF:
0.000595
AC:
659
AN:
1107964
Other (OTH)
AF:
0.000932
AC:
56
AN:
60076
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.479
Heterozygous variant carriers
0
49
98
146
195
244
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
28
56
84
112
140
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000526
AC:
80
AN:
152198
Hom.:
0
Cov.:
32
AF XY:
0.000551
AC XY:
41
AN XY:
74366
show subpopulations
African (AFR)
AF:
0.000121
AC:
5
AN:
41448
American (AMR)
AF:
0.000523
AC:
8
AN:
15292
Ashkenazi Jewish (ASJ)
AF:
0.00576
AC:
20
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5182
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4828
European-Finnish (FIN)
AF:
0.00113
AC:
12
AN:
10628
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
316
European-Non Finnish (NFE)
AF:
0.000441
AC:
30
AN:
68030
Other (OTH)
AF:
0.00239
AC:
5
AN:
2090
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.510
Heterozygous variant carriers
0
6
12
18
24
30
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000715
Hom.:
0
Bravo
AF:
0.000536

ClinVar

ClinVar submissions
Significance:Benign/Likely benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
3
not specified (3)
-
-
2
not provided (2)
-
-
2
Osteogenesis imperfecta (2)
-
-
1
Ehlers-Danlos syndrome (1)
-
-
1
Ehlers-Danlos syndrome, arthrochalasia type (1)
-
-
1
Infantile cortical hyperostosis (1)
-
-
1
Osteogenesis imperfecta type I (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.81
CADD
Benign
0.028
DANN
Benign
0.66
PhyloP100
-1.0

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs201091992; hg19: chr17-48269827; API